ArticleBlood cancer journal2013

Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study.

M Offidani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.